Home > Compound List > Product Information
Pirbuterol_Molecular_structure_CAS_38677-81-5)
Click picture or here to close

Pirbuterol

Catalog No. DB01291 Name DrugBank
CAS Number 38677-81-5 Website http://www.ualberta.ca/
M. F. C12H20N2O3 Telephone (780) 492-3111
M. W. 240.2988 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1145

SYNONYMS

IUPAC name
6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
IUPAC Traditional name
pyrbuterol
Brand Name
Maxair
Synonyms
Pirbuterolum [inn-latin]
Pirbuterol hydrochloride

DATABASE IDS

PubChem SID 46506379
CAS Number 38677-81-5
PubChem CID 4845

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.

The pharmacologic effects of beta adrenergic agonist drugs, including pirbuterol, are at least in proof attributable to stimulation through beta adrenergic receptors of intracellular adenyl cyclase, the enzyme which catalyzes the conversion of adenosine triphosphate (AlP) to cyclic-3? ,5?-adenosine monophosphate (c-AMP). Increased c-AMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.
Indication For the prevention and reversal of bronchospasm in patients 12 years of age and older with reversible bronchospasm including asthma.
Pharmacology Pirbuterol is a beta-2 adrenergic bronchodilator. In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 adrenergic receptors compared with isoproterenol. While it is recognized that beta-2 adrenergic receptors are the predominant receptors in bronchial smooth muscle, data indicate that there is a population of beta-2 receptors in the human heart, existing in a concentration between 10-50%. The precise function of these receptors has not been established.
Toxicity As with all sympathomimetic aerosol medication, cardiac arrest and even death may be associated with abuse of pirbuterol.
Affected Organisms
Humans and other mammals
Half Life The plasma half-life measured after oral administration is about two hours.
External Links
RxList
Drugs.com

REFERENCES